Purpose: The purpose of this study is to develop a method to reliably characterize multiple features of the corticospinal system in a more efficient manner than typically done in transcranial magnetic stimulation studies. Methods: Forty transcranial magnetic stimulation pulses of varying intensity were given over the first dorsal interosseous motor hot spot in 10 healthy adults. The first dorsal interosseous motor-evoked potential size was recorded during rest and activation to create recruitment curves. The Boltzmann sigmoidal function was fit to the data, and parameters relating to maximal motor-evoked potential size, curve slope, and stimulus intensity leading to half-maximal motor-evoked potential size were computed from the curve fit. Results: Good to excellent test–retest reliability was found for all corticospinal parameters at rest and during activation with 40 transcranial magnetic stimulation pulses. Conclusions: Through the use of curve fitting, important features of the corticospinal system can be determined with fewer stimuli than typically used for the same information. Determining the recruitment curve provides a basis to understand the state of the corticospinal system and select subject-specific parameters for transcranial magnetic stimulation testing quickly and without unnecessary exposure to magnetic stimulation. This method can be useful in individuals who have difficulty in maintaining stillness, including children and patients with motor disorders.
Recent studies have shown the presence of sensory dysfunction in adults with focal dystonias. The authors hypothesize that children with secondary dystonia due to cerebral palsy may share a similar sensory dysfunction. To test this hypothesis, they evaluated tactile spatial discrimination threshold using Johnson, Van Boven, Phillips domes in 10 children with cerebral palsy and upper extremity dystonia, 8 children with diplegic cerebral palsy without involvement of the arms, and 21 unaffected children. Both patient groups had poor tactile discrimination compared with controls. The authors therefore conclude that children with secondary dystonia and diplegia due to cerebral palsy have deficits of tactile sensation that are similar to deficits seen in adults with focal dystonia. These results are the first to test the spatial discrimination threshold using Johnson, Van Boven, Phillips domes in children with cerebral palsy.
There is anatomical and functional connectivity between the primary motor cortex (M1) and posterior parietal cortex (PPC) that plays a role in sensorimotor integration. In this study, we applied corticocortical paired-associative stimuli to ipsilateral PPC and M1 (parietal ccPAS) in healthy right-handed subjects to test if this procedure could modulate M1 excitability and PPC–M1 connectivity. One hundred and eighty paired transcranial magnetic stimuli to the PPC and M1 at an interstimulus interval (ISI) of 8 ms were delivered at 0.2 Hz. We found that parietal ccPAS in the left hemisphere increased the excitability of conditioned left M1 assessed by motor evoked potentials (MEPs) and the input–output curve. Motor behavior assessed by the Purdue pegboard task was unchanged compared with controls. At baseline, conditioning stimuli over the left PPC potentiated MEPs from left M1 when ISI was 8 ms. This interaction significantly attenuated at 60 min after left parietal ccPAS. Additional experiments showed that parietal ccPAS induced plasticity was timing-dependent, was absent if ISI was 100 ms, and could also be seen in the right hemisphere. Our results suggest that parietal ccPAS can modulate M1 excitability and PPC–M1 connectivity and is a new approach to modify motor excitability and sensorimotor interaction.
Surround inhibition is a neural mechanism that assists in the focusing of excitatory drive to muscles responsible for a given movement (agonist muscles) by suppressing unwanted activity in muscles not relevant to the movement (surround muscles). The purpose of the study was to determine the contribution of γ‐aminobutyric acidB receptor‐mediated intracortical inhibition, as assessed by the cortical silent period (CSP), to the generation of surround inhibition in the motor system. Eight healthy adults (five women and three men, 29.8 ± 9 years) performed isometric contractions with the abductor digiti minimi (ADM) muscle in separate conditions with and without an index finger flexion movement. The ADM motor evoked potential amplitude and CSP duration elicited by transcranial magnetic stimulation were compared between a control condition in which the ADM was activated independently and during conditions involving three phases (pre‐motor, phasic, and tonic) of the index finger flexion movement. The motor evoked potential amplitude of the ADM was greater during the control condition compared with the phasic condition. Thus, the presence of surround inhibition was confirmed in the present study. Most critically, the CSP duration of the ADM decreased during the phasic stage of finger flexion compared with the control condition, which indicated a reduction of this type of intracortical inhibition during the phasic condition. These findings indicate that γ‐aminobutyric acidB receptor‐mediated intracortical inhibition, as measured by the duration of the CSP, does not contribute to the generation of surround inhibition in hand muscles.
14 June 2004 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
This study explores the effects of functional electrical stimulation (FES) of the lumbar trunk extensors on the seated posture and bimanual workspace of subjects with spinal cord injury (SCI). Four subjects with motor complete SCI with implanted intramuscular stimulating electrodes to activate the lumbar erector spinae were studied. The positions of markers on the pelvis, trunk, and hands were monitored by a motion capture system during bimanual reaching maneuvers. To define three-dimensional functional workspace boundaries, subjects swept their hands through the extremes of their range of motion without losing balance while sitting. To characterize forward reach, subjects reached to targets in the sagittal plane while carrying various masses with and without FES. Reaching trials were rated on the seven-point usability rating scale to determine effort and subject preference and change in pelvic angle with stimulation was monitored. There was a consistent change in the seated posture with FES in all subjects that resulted in significant forward or upward (6.85 cm /spl plusmn/ 2.15 cm) shifts in the workspace. Workspace volumes increased for two of the four subjects tested. FES caused significant anterior rotation of the pelvis to restore a more natural lumbar curve without a backrest (19.81/spl deg/ /spl plusmn/ 8.75/spl deg/). With a backrest, the change in posture with FES allowed individuals with SCI to reach further in the sagittal plane and carry heavier masses by shifting the trunk, allowing increased elbow extension, or a combination of the two mechanisms. Reaching with FES was consistently preferred over reaching without FES. This preliminary study is encouraging for future research on trunk stability and reaching ability with FES.
Seven children between 2 and 15 years of age with cerebral palsy and upper extremity dystonia were enrolled in an open-label, dose-escalation pilot clinical trial of botulinum toxin type B (Myobloc), injected into the biceps and brachioradialis muscles of 1 or both arms. The primary outcome measure was the change in maximum speed of hand movement during attempted forward reaching. Escalating doses of 12.5, 25, and 50 U/kg per muscle were injected at each of 3 visits. Reaching speed improved in response to injection, and dystonia scores on the Burke-Fahn-Marsden dystonia scale, the Unified Dystonia Rating Scale, and the Unified Parkinson's Disease Rating Scale improved. There was not a dose-related effect on efficacy. There were no serious adverse events. Two children reported transient weakness. These results support the use of botulinum toxin type B as a safe and effective treatment for upper extremity dystonia in children with cerebral palsy. Larger controlled trials are needed to confirm these results.